To include your compound in the COVID-19 Resource Center, submit it here.

Biogen beats Street EPS

BGEN reported third quarter EPS of $0.37, beating by $0.02 the Street's $0.35

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE